Literature DB >> 18720023

Altered renal morphology in transgenic mice with cholecystokinin overexpression.

Marina Aunapuu1, Peeter Roosaar, Tõnu Järveots, Kaido Kurrikoff, Sulev Kõks, Eero Vasar, Andres Arend.   

Abstract

Although cholecystokinin is a regulatory peptide with a predominant role in the brain and the gastrointestinal tract, there is an increasing evidence for its role in the kidney. The aim of this study was to reveal morphological changes in the structure of kidney of mice with cholecystokinin overexpression by means of light, transmission and scanning electron microscope, and atomic force microscopy. Using immunohistochemistry the expression of important basement membrane proteins collagen IV, laminin and fibronectin, as well the distribution of cholecystokinin-8 in the renal structures was evaluated. The altered morphology of kidneys of mice with cholecystokinin overexpression was seen by all microscopic techniques used. The renal corpuscles were relatively small with narrow capsular lumen. The basement membranes of renal tubules were thickened and the epithelial cells were damaged, which was more pronounced for distal tubules. Characteristic feature was the increased number of vesicles seen throughout the epithelial cells of proximal and especially in distal tubules reflecting to the enhanced cellular degeneration. The relative expression of laminin but not collagen IV in the glomerular basement membrane was higher than in the tubular basement membranes. The content of fibronectin, in opposite, was higher in tubular membranes. Cholecystokinin-8 was clearly expressed in the glomeruli, in Bowman's capsule, in proximal and distal tubules, and in collecting ducts. Ultrastructural studies showed irregularly thickened glomerular basement membranes to which elongated cytopodia of differently shaped podocytes were attached. As foot processes were often fused the number of filtration pores was decreased. In conclusion, cholecystokinin plays important role in renal structural formation and in functioning as different aspects of urine production in mice with cholecystokinin overexpression are affected-the uneven glomerular basement membrane thickening, structural changes in podocytes and in filtration slits affect glomerular filtration, while damaged tubular epithelial cells and changed composition of thickened tubular basement membranes affect reabsorption.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18720023     DOI: 10.1007/s11248-008-9204-5

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  21 in total

1.  Deletion of the CCK2 receptor gene reduces mechanical sensitivity and abolishes the development of hyperalgesia in mononeuropathic mice.

Authors:  Kaido Kurrikoff; Sulev Kõks; Toshimitsu Matsui; Michel Bourin; Andres Arend; Marina Aunapuu; Eero Vasar
Journal:  Eur J Neurosci       Date:  2004-09       Impact factor: 3.386

Review 2.  An overview of the biophysical applications of atomic force microscopy.

Authors:  Nuno C Santos; Miguel A R B Castanho
Journal:  Biophys Chem       Date:  2004-02-01       Impact factor: 2.352

3.  The glomerular filter: Biologic and genetic complexity.

Authors:  S V Dandapani; M R Pollak
Journal:  Kidney Int       Date:  2006-09       Impact factor: 10.612

4.  The glomerular basement membrane: not gone, just forgotten.

Authors:  Marilyn G Farquhar
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

5.  Domain IV of mouse laminin beta1 and beta2 chains.

Authors:  Takako Sasaki; Karlheinz Mann; Jeffrey H Miner; Nicolai Miosge; Rupert Timpl
Journal:  Eur J Biochem       Date:  2002-01

6.  Gastrin/cholecystokinin type B receptors in the kidney: molecular, pharmacological, functional characterization, and localization.

Authors:  A de Weerth; L Jonas; R Schade; T Schöneberg; G Wolf; A Pace; F Kirchhoff; M Schulz; T Heinig; H Greten; T von Schrenck
Journal:  Eur J Clin Invest       Date:  1998-07       Impact factor: 4.686

7.  Inducible podocyte-specific gene expression in transgenic mice.

Authors:  Tetsuya Shigehara; Concepcion Zaragoza; Chagriya Kitiyakara; Hideko Takahashi; Huiyan Lu; Marcus Moeller; Lawrence B Holzman; Jeffrey B Kopp
Journal:  J Am Soc Nephrol       Date:  2003-08       Impact factor: 10.121

8.  High gastrin and cholecystokinin (CCK) gene expression in human neuronal, renal, and myogenic stem cell tumors: comparison with CCK-A and CCK-B receptor contents.

Authors:  J C Schaer; J C Reubi
Journal:  J Clin Endocrinol Metab       Date:  1999-01       Impact factor: 5.958

9.  Laminin and fibronectin content of mouse glomerular and tubular basement membrane.

Authors:  D K Brees; R C Ogle; J C Williams
Journal:  Ren Physiol Biochem       Date:  1995 Jan-Feb

Review 10.  Cholecystokinin receptors.

Authors:  S A Wank
Journal:  Am J Physiol       Date:  1995-11
View more
  4 in total

1.  Cholecystokinin plays a novel protective role in diabetic kidney through anti-inflammatory actions on macrophage: anti-inflammatory effect of cholecystokinin.

Authors:  Satoshi Miyamoto; Kenichi Shikata; Kyoko Miyasaka; Shinichi Okada; Motofumi Sasaki; Ryo Kodera; Daisho Hirota; Nobuo Kajitani; Tetsuharu Takatsuka; Hitomi Usui Kataoka; Shingo Nishishita; Chikage Sato; Akihiro Funakoshi; Hisakazu Nishimori; Haruhito Adam Uchida; Daisuke Ogawa; Hirofumi Makino
Journal:  Diabetes       Date:  2012-02-22       Impact factor: 9.461

Review 2.  Cholecystokinin-From Local Gut Hormone to Ubiquitous Messenger.

Authors:  Jens F Rehfeld
Journal:  Front Endocrinol (Lausanne)       Date:  2017-04-13       Impact factor: 5.555

3.  Low protein diet inhibits uric acid synthesis and attenuates renal damage in streptozotocin-induced diabetic rats.

Authors:  Jianmin Ran; Jing Ma; Yan Liu; Rongshao Tan; Houqiang Liu; Gancheng Lao
Journal:  J Diabetes Res       Date:  2014-03-13       Impact factor: 4.011

Review 4.  Gastrin, Cholecystokinin, Signaling, and Biological Activities in Cellular Processes.

Authors:  Qiang Zeng; Lei Ou; Wei Wang; Dong-Yu Guo
Journal:  Front Endocrinol (Lausanne)       Date:  2020-03-06       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.